Refractory catatonia in old age: a case report.
Emma Bean1,2, Callum Findlay1,2, Claire Gee2
1University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
Journal of Medical Case Reports
|August 14, 2021
Summary
Catatonia in older adults is often missed and difficult to treat. This case highlights the challenges and prognostic factors for managing catatonia in the elderly.
Area of Science:
- Geriatric Psychiatry
- Neuroscience
- Clinical Psychology
Background:
- Catatonia, a syndrome of psychomotor disruption, is frequently underdiagnosed in older adults.
- Existing research on catatonia primarily focuses on younger populations and schizophrenia, leaving a knowledge gap regarding elderly patients.
- The clinical presentation and progression of catatonia in old age remain poorly understood.
Observation:
- A 73-year-old male with a history of autistic spectrum disorder presented with depressive symptoms.
- Initial treatment with antidepressants was ineffective, but a lorazepam challenge resulted in temporary improvement.
- The patient experienced a 16-month hospital admission with extensive treatment including lorazepam, zolpidem, and electroconvulsive therapy, yet remained refractory to treatment.
Findings:
- Catatonia requires prompt consideration in older individuals presenting with atypical psychiatric symptoms.
- While benzodiazepines and electroconvulsive therapy offered partial, unsustained improvement, the patient's catatonia was ultimately refractory.
- Comorbid autistic spectrum disorder, prolonged catatonia duration, and benzodiazepine sensitivity were identified as key prognostic factors in this elderly patient.
Implications:
- Catatonia should be a key differential diagnosis for older patients with unusual functional mental illness symptoms.
- Understanding prognostic factors like autistic spectrum disorder and benzodiazepine sensitivity is crucial for managing catatonia in the elderly.
- This case underscores the need for further research into effective, sustained treatments for catatonia in geriatric populations.
Related Concept Videos
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...


